These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6133639)

  • 1. Future possibilities for conducting clinical trials to test the efficacy of beta-blocker medications.
    Naughton J
    Circulation; 1983 Jun; 67(6 Pt 2):I106-9. PubMed ID: 6133639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.
    Smith DH; Kramer JM; Perrin N; Platt R; Roblin DW; Lane K; Goodman M; Nelson WW; Yang X; Soumerai SB
    Arch Intern Med; 2008 Mar; 168(5):477-83; discussion 483; quiz 447. PubMed ID: 18332291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of inpatient initiation of beta-blockers.
    Ventura HO
    Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction.
    Fonarow GC
    Cardiol Clin; 2008 Feb; 26(1):79-89, vii. PubMed ID: 18312908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
    Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intravenous beta blockade in acute myocardial infarction.
    Yusuf S
    Postgrad Med; 1988 Feb; Spec No():90-5. PubMed ID: 2894666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
    Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.